These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6940776)

  • 21. Comparison of cationic-surfactant and phenol-based mouthwash-gargles in relieving oropharyngeal pain.
    Breazeale J
    J Am Coll Health Assoc; 1974 Dec; 23(2):165-6. PubMed ID: 4613746
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of cetylpyridinium chloride containing lozenges on dental plaque and gingival bleeding.
    Barnes GP; Radentz WH; Perkins BE
    J Prev Dent; 1975; 2(5):2-4, 6. PubMed ID: 1088597
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical trial of a cetylpyridinium dentifrice].
    Rebstein F; de Crousaz P; Corti M; Jaccard F; Matter J; Huber P; Cimasoni G
    SSO Schweiz Monatsschr Zahnheilkd; 1981 Jan; 91(1):51-7. PubMed ID: 7017921
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of cetylpridinium chloride on human plaque bacteria and gingivitis.
    Lobene RR; Kashket S; Soparkar PM; Shloss J; Sabine ZM
    Pharmacol Ther Dent; 1979; 4(1):33-47. PubMed ID: 295121
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental and clinical studies of TDZ, a new dental hemostatic].
    Sekine I; Yoshida R; Watanabe Y; Yamashita H; Koyama Y
    Shikai Tenbo; 1980 Jul; 56(1):173-80. PubMed ID: 6968280
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical use of a new drug association in suppository form in some ano-rectal diseases].
    Petterino E; Calogero G
    Minerva Med; 1970 Aug; 61(63):3401-6. PubMed ID: 5451086
    [No Abstract]   [Full Text] [Related]  

  • 27. Practice implications with an alcohol-free, 0.07% cetylpyridinium chloride mouthrinse.
    Blenman TV; Morrison KL; Tsau GJ; Medina AL; Gerlach RW
    Am J Dent; 2005 Jul; 18 Spec No():29A-34A. PubMed ID: 16178134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gallstone dissolution in vitro by bile acids, heparin, and quanternary amines.
    Lahana DA; Bonorris GG; Schoenfield LJ
    Surg Gynecol Obstet; 1974 May; 138(5):683-5. PubMed ID: 4823370
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative cytological studies after gingivectomy and flap surgery].
    Mutschelknauss R; Flores de Jacoby L; Wortmann K
    Dtsch Zahnarztl Z; 1976 May; 31(5):435-8. PubMed ID: 1065569
    [No Abstract]   [Full Text] [Related]  

  • 30. [Stosstherapy with steroid-containing combination preparation "Ambene" in the acute stages of rheumatic diseases].
    Chalabi G
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):405-8. PubMed ID: 804605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of the effectiveness of an antiseptic and local anesthetic solution, in postoperative periodontal surgery].
    de Lima SN; Maia Campos G; Verri RA
    Rev Fac Odontol Ribeiro Preto; 1984; 21(1):1-15. PubMed ID: 6599627
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride in preventing dental plaque.
    Lotufo R; Calil CM; Feng HS; Sekiguchi RT; Stewart B; DeVizio W; Proskin HM
    J Clin Dent; 2009; 20(2):50-4. PubMed ID: 19591337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Problems associated with abutment building and periodontal tissue--clinical cases].
    Komahashi H
    Shikai Tenbo; 1979; 53(4):591-9. PubMed ID: 397116
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of human fibrin glue in the dental surgery of hemophilic patients].
    Micheletti G; Marcucci M; Patane F; Panattoni E
    Dent Cadmos; 1983 May; 51(5):39-46. PubMed ID: 6365610
    [No Abstract]   [Full Text] [Related]  

  • 35. A clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride to control established dental plaque and gingivitis.
    Silva MF; dos Santos NB; Stewart B; DeVizio W; Proskin HM
    J Clin Dent; 2009; 20(2):55-61. PubMed ID: 19591338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A new drug combination with antitussive activity (clinical experimentation)].
    Martelli A
    Policlinico Med; 1968; 75(1):49-68. PubMed ID: 5739280
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of sodium oxyferriscorbone, lidocaine and therapeutic endoscopy in peptic ulcer].
    Starodub EM; Zhukovskiĭ MN; Shust ZI; Faryniuk SG; Markiv IM
    Vrach Delo; 1984 Sep; (9):11-3. PubMed ID: 6506628
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cetylpyridinium chloride mouthwashes. Comparative effects of scaling alone or with mouthwash].
    Hitzig C; Charbit Y; Varonne R; Teboul M; Souci J; Bitton C; Brumpt P; Douider N
    Inf Dent; 1991 May; 73(19):1499-502. PubMed ID: 2045183
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experience in the use of the local hemostatic agent Kaprofer in otorhinolaryngologic practice].
    Dunaĭvitser BI; Gulunian EA; Lalaev KV; Manukian VM
    Vestn Otorinolaringol; 1987; (5):71-3. PubMed ID: 3424525
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of a mouthrinse containing 0.05% cetylpyridinium chloride for the control of plaque and gingivitis: a 6-month clinical study in adults.
    Allen DR; Davies R; Bradshaw B; Ellwood R; Simone AJ; Robinson R; Mukerjee C; Petrone ME; Chaknis P; Volpe AR; Proskin HM
    Compend Contin Educ Dent; 1998; 19(2 Suppl):20-6. PubMed ID: 10371878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.